KRT8 (Keratin, type II cytoskeletal 8) variants and mutations
KRT8 (also known as Keratin, type II cytoskeletal 8) is a human protein-coding gene encoding a keratin, type II cytoskeletal 8 protein. It pairs with keratin 18 to form the major intermediate-filament network of simple epithelial cells and helps protect tissues from mechanical and metabolic stress. Rare variants have been associated with susceptibility to liver and pancreatic disease, although penetrance is variable. This analysis covers 860 KRT8 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes Cirrhosis, cirrhosis, familial, and neurodegenerative disease. Example KRT8 variants include M1?, T6A, and Q7P.
Variant analysis overview
- Gene: KRT8
- Protein: Keratin, type II cytoskeletal 8
- UniProt accession: P05787
- Organism: Homo sapiens
- Variants analyzed: 860
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 611 unspecified-consequence records; 2 stop lost; 21 frameshift variants; 116 missense variants; 93 synonymous variants; 6 stop-gained variants; 3 in-frame insertions; 4 in-frame deletions; 2 splice-region variants; 4 substitution
- Prediction scores: 683 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Cirrhosis, cirrhosis, familial, neurodegenerative disease, exocrine pancreatic carcinoma, prostate carcinoma, Abnormality of the liver, sick sinus syndrome, familial sick sinus syndrome, Alzheimer disease, Parkinson disease, lysosomal storage disease, multiple sclerosis.
Protein structure and variant hotspots
- Protein features: 1 domains; 39 post-translational modification sites.
- Structural context: 456 variants have structural context.
- PTM context: 73 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT8 variants
Examples include M1?, T6A, Q7P, Q7R, K8R, S9A, S9F, S9Y. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV99509
- T6A (p.Thr6Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q7P (p.Gln7Pro), TOPMed rs1315928015, gnomAD rs1315928015, CADD 24.80, PolyPhen-2 0.47, Uncertain significance, not specified
- Q7R (p.Gln7Arg), TOPMed rs1315928015, gnomAD rs1315928015, CADD 21.10, PolyPhen-2 0.01
- K8R (p.Lys8Arg), 1000Genomes rs560670999, ExAC rs560670999, TOPMed rs560670999, gnomAD rs560670999, CADD 23.00, PolyPhen-2 0.16
- S9A (p.Ser9Ala), rs549320537, ClinGen CA6590642, ClinVar RCV004309841, 1000Genomes rs549320537, CADD 22.70, PolyPhen-2 0.22, Uncertain significance, not specified
- S9F (p.Ser9Phe), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53177, Variant assessed as somatic; moderate impact.
- S9Y (p.Ser9Tyr), gnomAD rs1391875173, CADD 24.30, PolyPhen-2 0.59
- V12A (p.Val12Ala), gnomAD rs1389976717, CADD 23.50, PolyPhen-2 0.02
- S13F (p.Ser13Phe), ExAC rs746423423, gnomAD rs746423423, CADD 23.10, PolyPhen-2 0.12
- S13P (p.Ser13Pro), Ensembl rs775699573
- T14I (p.Thr14Ile), ExAC rs781721772, CADD 19.10, PolyPhen-2 0.04
- T14P (p.Thr14Pro), Ensembl rs1592166552
- S15F (p.Ser15Phe), cosmic curated COSV53177, ExAC rs757605500, gnomAD rs757605500, CADD 25.70, PolyPhen-2 0.95
- G16V (p.Gly16Val), rs79476176, []
- P17L (p.Pro17Leu), gnomAD rs1231506237
- P17S (p.Pro17Ser), rs754652686, ClinGen CA6590637, ClinVar RCV004357943, ExAC rs754652686, CADD 22.40, PolyPhen-2 0.12, Uncertain significance, not specified
- P17T (p.Pro17Thr), ExAC rs754652686, gnomAD rs754652686, CADD 23.10, PolyPhen-2 0.08, Uncertain significance
- R18G (p.Arg18Gly), 1000Genomes rs11554484, ExAC rs11554484, TOPMed rs11554484, gnomAD rs11554484, CADD 18.50, PolyPhen-2 0.00
- R18L (p.Arg18Leu), ExAC rs755636595, TOPMed rs755636595, gnomAD rs755636595, CADD 22.40, PolyPhen-2 0.07
- R18Q (p.Arg18Gln), ExAC rs755636595, TOPMed rs755636595, gnomAD rs755636595, CADD 22.60, PolyPhen-2 0.00
- R18W (p.Arg18Trp), 1000Genomes rs11554484, ExAC rs11554484, TOPMed rs11554484, gnomAD rs11554484, CADD 21.80, PolyPhen-2 0.00
- A19D (p.Ala19Asp), ExAC rs750392549, TOPMed rs750392549, gnomAD rs750392549, CADD 22.60, PolyPhen-2 0.05
- A19V (p.Ala19Val), ExAC rs750392549, TOPMed rs750392549, gnomAD rs750392549, CADD 22.50, PolyPhen-2 0.05
- S21R (p.Ser21Arg), Ensembl rs1592166496
- S21T (p.Ser21Thr), Ensembl rs1592166489, CADD 25.60, PolyPhen-2 0.82
- S22C (p.Ser22Cys), ExAC rs767456684, gnomAD rs767456684, CADD 27.70, PolyPhen-2 0.89
- S22T (p.Ser22Thr), cosmic curated COSV10609
- R23C (p.Arg23Cys), cosmic curated COSV53175, ExAC rs201807576, gnomAD rs201807576, CADD 23.10, PolyPhen-2 0.00
- S24F (p.Ser24Phe), ExAC rs774320109, TOPMed rs774320109, gnomAD rs774320109, CADD 23.80, PolyPhen-2 0.05, Uncertain significance, not specified
- S24Y (p.Ser24Tyr), ExAC rs774320109, TOPMed rs774320109, gnomAD rs774320109, CADD 25.50, PolyPhen-2 0.59
- Y25* (p.Tyr25Ter), Ensembl rs1941476526
- T26R (p.Thr26Arg), rs57286292, ClinGen CA217270, ClinVar RCV000056942, Ensembl rs57286292, AlphaMissense 0.52, MetaLR 0.27, not provided
- S27N (p.Ser27Asn), gnomAD rs1351844057, CADD 19.10, PolyPhen-2 0.76
- P29A (p.Pro29Ala), 1000Genomes rs2120584258, CADD 21.60
- P29L (p.Pro29Leu), cosmic curated COSV10735, CADD 23.30, PolyPhen-2 0.84
- G30C (p.Gly30Cys), TOPMed rs1321446458, gnomAD rs1321446458
- G30D (p.Gly30Asp), rs777050332, ExAC rs777050332, gnomAD rs777050332, AlphaMissense 0.59, MetaLR 0.67, Variant assessed as somatic; moderate impact.
- G30S (p.Gly30Ser), TOPMed rs1321446458, gnomAD rs1321446458, CADD 3.22, PolyPhen-2 0.03
- S31A (p.Ser31Ala), cosmic curated COSV53175, ExAC rs771489011, gnomAD rs771489011, CADD 0.00, PolyPhen-2 0.00
- S31F (p.Ser31Phe), TOPMed rs1413919473, gnomAD rs1413919473, CADD 19.50, PolyPhen-2 0.16
- S31Y (p.Ser31Tyr), cosmic curated COSV53176
- R32C (p.Arg32Cys), ExAC rs747471242, gnomAD rs747471242, CADD 19.90, PolyPhen-2 0.00
- R32H (p.Arg32His), cosmic curated COSV10963, ExAC rs778111216, TOPMed rs778111216, gnomAD rs778111216, CADD 16.80, PolyPhen-2 0.00, Uncertain significance
- R32P (p.Arg32Pro), rs778111216, ClinGen CA6590620, ClinVar RCV004341660, ExAC rs778111216, CADD 22.10, PolyPhen-2 0.01, Uncertain significance, not specified
- S34N (p.Ser34Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S34R (p.Ser34Arg), gnomAD rs1158806302, CADD 22.80, PolyPhen-2 0.13
- S35F (p.Ser35Phe), cosmic curated COSV53179
- S35T (p.Ser35Thr), ExAC rs758703720, gnomAD rs758703720, CADD 21.90, PolyPhen-2 0.06
- S35Y (p.Ser35Tyr), ExAC rs748998235, gnomAD rs748998235, CADD 22.40, PolyPhen-2 0.06
- S36A (p.Ser36Ala), gnomAD rs1197887525, CADD 22.10, PolyPhen-2 0.00
- S36L (p.Ser36Leu), rs779675126, NCI-TCGA Cosmic COSV5317, cosmic curated COSV53176, ExAC rs779675126, CADD 22.60, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- S36W (p.Ser36Trp), NCI-TCGA Cosmic COSV5317, Variant assessed as somatic; moderate impact.
- S37C (p.Ser37Cys), cosmic curated COSV53176
- R40* (p.Arg40Ter), cosmic curated COSV10587, ExAC rs757223465, gnomAD rs757223465, CADD 37.00
- R40Q (p.Arg40Gln), cosmic curated COSV10512, NCI-TCGA TCGA novel, Uncertain significance, not specified
- V41E (p.Val41Glu), Ensembl rs1592166398
- V41G (p.Val41Gly), Ensembl rs1592166398
- V41M (p.Val41Met), gnomAD rs1267862887, CADD 15.50
- G42C (p.Gly42Cys), TOPMed rs1349921419, gnomAD rs1349921419, CADD 23.70, PolyPhen-2 0.38
- G42D (p.Gly42Asp), ExAC rs751485389, gnomAD rs751485389
- G42R (p.Gly42Arg), TOPMed rs1349921419, gnomAD rs1349921419
- S43G (p.Ser43Gly), TOPMed rs923432670, gnomAD rs923432670, CADD 16.20, PolyPhen-2 0.00
- S43I (p.Ser43Ile), cosmic curated COSV53176
- S43N (p.Ser43Asn), ExAC rs764041785, gnomAD rs764041785, CADD 23.10, PolyPhen-2 0.45
- S43R (p.Ser43Arg), cosmic curated COSV53176
- N45D (p.Asn45Asp), Ensembl rs1941473766
- R47G (p.Arg47Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R47P (p.Arg47Pro), ExAC rs775896565, gnomAD rs775896565, CADD 23.20, PolyPhen-2 0.55
- R47S (p.Arg47Ser), ExAC rs762840989, TOPMed rs762840989, gnomAD rs762840989, CADD 17.10, PolyPhen-2 0.02
- G48R (p.Gly48Arg), cosmic curated COSV53177
- G48S (p.Gly48Ser), ExAC rs765478121, TOPMed rs765478121, gnomAD rs765478121, CADD 2.59, PolyPhen-2 0.09
- G49D (p.Gly49Asp), cosmic curated COSV10809
- G49S (p.Gly49Ser), NCI-TCGA TCGA novel, CADD 7.53, PolyPhen-2 0.25, Variant assessed as somatic; moderate impact.
- G49V (p.Gly49Val), 1000Genomes rs537655743, ExAC rs537655743, gnomAD rs537655743, CADD 18.50, PolyPhen-2 0.25
- L50P (p.Leu50Pro), TOPMed rs1941472861, gnomAD rs1941472861, CADD 22.60
- L50V (p.Leu50Val), Ensembl rs1941472952
- G51R (p.Gly51Arg), cosmic curated COSV53177
- G51S (p.Gly51Ser), ExAC rs200996175, gnomAD rs200996175, CADD 15.40, PolyPhen-2 0.12
- G51V (p.Gly51Val), ExAC rs747524509, gnomAD rs747524509, CADD 19.70, PolyPhen-2 0.70
- G52S (p.Gly52Ser), gnomAD rs1481688006, CADD 9.05, PolyPhen-2 0.01
- G52V (p.Gly52Val), cosmic curated COSV53176
- G53D (p.Gly53Asp), ExAC rs61710484, TOPMed rs61710484, gnomAD rs61710484, CADD 19.20, PolyPhen-2 0.05, Uncertain significance
- G53R (p.Gly53Arg), TOPMed rs531316453, gnomAD rs531316453, CADD 19.40, PolyPhen-2 0.09, Uncertain significance
- G53S (p.Gly53Ser), TOPMed rs531316453, gnomAD rs531316453, CADD 14.50, PolyPhen-2 0.06, Uncertain significance
- G53V (p.Gly53Val), rs61710484, ClinGen CA217260, ClinVar RCV000056935, UniProt VAR 023058, CADD 22.70, PolyPhen-2 0.59, not provided
- Y54C (p.Tyr54Cys), rs2120583347, ClinGen CA384997242, cosmic curated COSV99509, ClinVar RCV001765401, AlphaMissense 0.07, MetaLR 0.69, Uncertain significance, not provided
- Y54H (p.Tyr54His), rs57749775, ClinGen CA124165, ClinVar RCV000015737, ClinVar RCV000056936, CADD 16.50, PolyPhen-2 0.03, Benign, not specified; Hepatitis C virus, susceptibility to
- Y54N (p.Tyr54Asn), 1000Genomes rs57749775, ESP rs57749775, ExAC rs57749775, TOPMed rs57749775, CADD 23.00, PolyPhen-2 0.44, Benign
- G55A (p.Gly55Ala), rs57282588, ClinGen CA217262, cosmic curated COSV53176, ClinVar RCV000056937, CADD 2.51, PolyPhen-2 0.01, not provided
- G56E (p.Gly56Glu), gnomAD rs1260986065, CADD 20.20, PolyPhen-2 0.84
- A57T (p.Ala57Thr), 1000Genomes rs555181492, ExAC rs555181492, gnomAD rs555181492, CADD 16.00, PolyPhen-2 0.49
- A57V (p.Ala57Val), cosmic curated COSV53176
- S58N (p.Ser58Asn), 1000Genomes rs536780728, ExAC rs536780728, TOPMed rs536780728, gnomAD rs536780728, CADD 11.00, PolyPhen-2 0.24, Uncertain significance, not specified
- S58R (p.Ser58Arg), ExAC rs758320532, gnomAD rs758320532, CADD 0.03, PolyPhen-2 0.01
- M60I (p.Met60Ile), cosmic curated COSV53176
- M60V (p.Met60Val), TOPMed rs1181183046, CADD 0.01, PolyPhen-2 0.00
- G61* (p.Gly61Ter), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53177, Variant assessed as somatic; high impact.
- G62C (p.Gly62Cys), rs11554495, ClinGen CA124163, cosmic curated COSV99035, ClinVar RCV000015735, CADD 22.20, PolyPhen-2 0.95, Benign/Likely benign, not specified; not provided
- I63T (p.Ile63Thr), TOPMed rs1941470640, gnomAD rs1941470640, CADD 23.60
- I63V (p.Ile63Val), rs59536457, ClinGen CA217264, cosmic curated COSV53177, ClinVar RCV000056939, CADD 24.10, PolyPhen-2 0.28, Benign/Likely benign, Inflammatory bowel disease; not specified; not provided
- T64A (p.Thr64Ala), cosmic curated COSV53179
- A65P (p.Ala65Pro), ExAC rs759804104, TOPMed rs759804104, gnomAD rs759804104
- A65T (p.Ala65Thr), ExAC rs759804104, TOPMed rs759804104, gnomAD rs759804104, CADD 14.40, PolyPhen-2 0.04
- A65V (p.Ala65Val), ExAC rs753945275, gnomAD rs753945275, CADD 24.40, PolyPhen-2 0.61
- V66I (p.Val66Ile), ExAC rs766537083, gnomAD rs766537083, CADD 17.40, PolyPhen-2 0.01
- T67K (p.Thr67Lys), gnomAD rs1407319102, CADD 23.00, PolyPhen-2 0.30
- N69I (p.Asn69Ile), ExAC rs773747000, TOPMed rs773747000, gnomAD rs773747000, CADD 26.60
- N69S (p.Asn69Ser), cosmic curated COSV10512, ExAC rs773747000, TOPMed rs773747000, gnomAD rs773747000, CADD 23.30, PolyPhen-2 0.12
- Q70X, rs78514003, []
- S71R (p.Ser71Arg), TOPMed rs1002990848, gnomAD rs1002990848, CADD 25.00, PolyPhen-2 0.76
- L73R (p.Leu73Arg), rs2539433351, ClinGen CA384997126, ClinVar RCV004414551, Uncertain significance, not specified
- S74N (p.Ser74Asn), Ensembl rs1372766833
- L76F (p.Leu76Phe), cosmic curated COSV10735
- L76P (p.Leu76Pro), Ensembl rs1941469030
- L76R (p.Leu76Arg), Ensembl rs1941469030, CADD 22.90, PolyPhen-2 0.03
- V77G (p.Val77Gly), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53179, Variant assessed as somatic; moderate impact.
- L78Q (p.Leu78Gln), gnomAD rs1941468677, CADD 24.20
- E79K (p.Glu79Lys), TOPMed rs1941468487
- V80M (p.Val80Met), cosmic curated COSV10735
- D81N (p.Asp81Asn), gnomAD rs1202340708, CADD 24.40, PolyPhen-2 0.16
- P82H (p.Pro82His), cosmic curated COSV99510
- P82S (p.Pro82Ser), TOPMed rs1380444038, CADD 25.90, PolyPhen-2 0.84
- I84T (p.Ile84Thr), Ensembl rs11554494
- Q85E (p.Gln85Glu), 1000Genomes rs532491388, ExAC rs532491388, gnomAD rs532491388, CADD 24.40, PolyPhen-2 0.12
- A86V (p.Ala86Val), TOPMed rs1230540490, gnomAD rs1230540490, CADD 21.20, PolyPhen-2 0.02, Uncertain significance, not specified
- R88C (p.Arg88Cys), cosmic curated COSV53177, 1000Genomes rs571462252, ExAC rs571462252, gnomAD rs571462252
- R88S (p.Arg88Ser), 1000Genomes rs571462252, ExAC rs571462252, gnomAD rs571462252
- Q90E (p.Gln90Glu), TOPMed rs958536238, gnomAD rs958536238, CADD 23.20, PolyPhen-2 0.48
- Q94H (p.Gln94His), ESP rs138034250, ExAC rs138034250, TOPMed rs138034250
- I95L (p.Ile95Leu), ExAC rs758437742, TOPMed rs758437742, gnomAD rs758437742, CADD 25.20, PolyPhen-2 0.56
- I95N (p.Ile95Asn), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53177, Variant assessed as somatic; moderate impact.
- K96N (p.Lys96Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L98I (p.Leu98Ile), TOPMed rs1331169400, gnomAD rs1331169400, CADD 29.60, PolyPhen-2 0.90
- N99T (p.Asn99Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N100D (p.Asn100Asp), ExAC rs752507895, TOPMed rs752507895, gnomAD rs752507895, CADD 24.70, PolyPhen-2 0.91
- N100K (p.Asn100Lys), cosmic curated COSV53176
- A103P (p.Ala103Pro), cosmic curated COSV53176
- A103V (p.Ala103Val), gnomAD rs1356744191, CADD 26.80, PolyPhen-2 0.44
- S104A (p.Ser104Ala), cosmic curated COSV10880
- S104F (p.Ser104Phe), gnomAD rs1592166174, CADD 24.10, PolyPhen-2 0.24
- S104Y (p.Ser104Tyr), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53177, Variant assessed as somatic; moderate impact.
- S104R (p.Ser104Arg), rs796361379, []
- F105V (p.Phe105Val), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99509, Variant assessed as somatic; moderate impact.
- I106T (p.Ile106Thr), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53179, gnomAD rs1941466105, CADD 25.50, PolyPhen-2 0.25, Variant assessed as somatic; moderate impact.
- V109I (p.Val109Ile), gnomAD rs1941385295, CADD 24.50, PolyPhen-2 0.18
- R110L (p.Arg110Leu), ExAC rs750588420, TOPMed rs750588420, gnomAD rs750588420, CADD 23.00, PolyPhen-2 0.08
- R110Q (p.Arg110Gln), ExAC rs750588420, TOPMed rs750588420, gnomAD rs750588420, CADD 22.00, PolyPhen-2 0.06
- R110W (p.Arg110Trp), ESP rs145511223, ExAC rs145511223, gnomAD rs145511223, CADD 24.10, PolyPhen-2 0.08
- E113* (p.Glu113Ter), Ensembl rs2120564730, CADD 41.00
- E113V (p.Glu113Val), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53179, Variant assessed as somatic; moderate impact.
- Q115* (p.Gln115Ter), gnomAD rs1384365095, CADD 43.00
- Q115E (p.Gln115Glu), gnomAD rs1384365095, CADD 24.40, PolyPhen-2 0.40
- Q115H (p.Gln115His), NCI-TCGA TCGA novel, CADD 24.60, PolyPhen-2 0.89, Variant assessed as somatic; moderate impact.
- N116H (p.Asn116His), TOPMed rs1941384711
- N116K (p.Asn116Lys), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53178, CADD 24.60, PolyPhen-2 0.97, Variant assessed as somatic; moderate impact.
- K117E (p.Lys117Glu), TOPMed rs1274893384, gnomAD rs1274893384, CADD 28.40, PolyPhen-2 0.96
- K117N (p.Lys117Asn), TOPMed rs1287265741, gnomAD rs1287265741, CADD 25.10, PolyPhen-2 0.99
- K117Q (p.Lys117Gln), TOPMed rs1274893384, gnomAD rs1274893384, CADD 27.80, PolyPhen-2 0.97
- M118I (p.Met118Ile), gnomAD rs768237082
- M118L (p.Met118Leu), TOPMed rs1044439462, gnomAD rs1044439462
- M118V (p.Met118Val), TOPMed rs1044439462, gnomAD rs1044439462
- E120G (p.Glu120Gly), gnomAD rs1345554697, CADD 26.10, PolyPhen-2 0.52
- K122T (p.Lys122Thr), rs2539428475, ClinVar RCV004557765, Likely benign, EBV-positive nodal T- and NK-cell lymphoma
- W123C (p.Trp123Cys), NCI-TCGA Cosmic COSV5317, cosmic curated COSV53177, Variant assessed as somatic; moderate impact.
- S124N (p.Ser124Asn), Ensembl rs1941383930, CADD 13.50, PolyPhen-2 0.08
- L125F (p.Leu125Phe), gnomAD rs1431281990, CADD 23.20, PolyPhen-2 0.42
- Q128* (p.Gln128Ter), cosmic curated COSV99510, CADD 37.00
- Q129K (p.Gln129Lys), cosmic curated COSV10605, CADD 26.90, PolyPhen-2 0.86
- K130Q (p.Lys130Gln), gnomAD rs1200074492, CADD 23.20, PolyPhen-2 0.63
- T131M (p.Thr131Met), cosmic curated COSV99510, ExAC rs752152485, TOPMed rs752152485, gnomAD rs752152485, CADD 21.50, PolyPhen-2 0.06, Uncertain significance, not specified
- A132S (p.Ala132Ser), gnomAD rs1259134501, CADD 5.79, PolyPhen-2 0.18
- A132V (p.Ala132Val), ExAC rs764490389, gnomAD rs764490389, CADD 22.50, PolyPhen-2 0.79
- R133* (p.Arg133Ter), rs141850020, cosmic curated COSV99510, ESP rs141850020, ExAC rs141850020, CADD 33.00, Variant assessed as somatic; high impact.
- R133G (p.Arg133Gly), cosmic curated COSV10512, ESP rs141850020, ExAC rs141850020, TOPMed rs141850020, CADD 12.60, PolyPhen-2 0.00
- R133Q (p.Arg133Gln), rs775752489, cosmic curated COSV10587, ExAC rs775752489, gnomAD rs775752489, CADD 17.50, PolyPhen-2 0.02, Variant assessed as somatic; moderate impact.
- S134R (p.Ser134Arg), TOPMed rs1203391514, gnomAD rs1203391514, CADD 22.50, PolyPhen-2 0.25
- D137G (p.Asp137Gly), gnomAD rs1941382519
- D137N (p.Asp137Asn), TOPMed rs1479025322, CADD 23.10, PolyPhen-2 0.31
- M139K (p.Met139Lys), cosmic curated COSV53179, gnomAD rs1265482543, CADD 23.40, PolyPhen-2 0.67
Public KRT8 analysis runs
- KRT8 analysis run — KRT8 (860 variants) — completed 2026-08-22